Linden Advisors’s Envoy Medical COCH Stock Holding History

Linden Advisors’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-397,784	Closed	-$3.99M	–	471
2022 Q4	$3.99M	Hold	397,784	–	–	0.04%	233
2022 Q3	$3.91M	Hold	397,784	–	–	0.04%	267
2022 Q2	$3.9M	Hold	397,784	–	–	0.04%	285
2022 Q1	$3.89M	Hold	397,784	–	–	0.02%	378
2021 Q4	$3.88M	Hold	397,784	–	–	0.02%	360
2021 Q3	$3.86M	Hold	397,784	–	–	0.02%	352
2021 Q2	$3.86M	Buy	+397,784	New	+$3.87M	0.02%	387

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Linden Advisors's COCH Position: Q1 2023 in Review

Linden Advisors sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 397,784 shares — an estimated $3.99M sold.

Linden Advisors first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $3.99M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Linden Advisors reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Linden Advisors sold 397,784 Envoy Medical shares in Q1 2023, an estimated $3.99M.
Linden Advisors first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
Linden Advisors's Envoy Medical position peaked at $3.99M in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Linden Advisors's 13F filing for Q1 2023, filed 15 May 2023.